Protective effect of astaxanthin on ANCA-associated vasculitis

Int Immunopharmacol. 2024 May 10:132:111928. doi: 10.1016/j.intimp.2024.111928. Epub 2024 Mar 26.

Abstract

Objective: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease characterized by inflammation and fibrinoid necrosis of medium and small vessels, and its pathogenesis is closely related to inflammation and oxidative stress. Astaxanthin (ATX) is a carotenoid with anti-inflammatory, antioxidant, and immunomodulatory effects. We hypothesized that ATX could play a role in AAV treatment. This study aimed to investigate whether ATX has a protective effect against AAV and to elucidate its regulatory mechanism.

Methods: In vitro experiments, neutrophils isolated from healthy people were treated with ATX or not and cultured with serum from myeloperoxidase (MPO) -ANCA-positive patients and healthy persons. The levels of IL-6 and TNF-α in neutrophil culture supernatant before and after stimulation were measured. Neutrophil extracellular traps (NETs) and intracellular reactive oxygen species (ROS) in neutrophils were detected after stimulation. In vivo study, experimental autoimmune vasculitis (EAV) rat models were established and then treated with ATX via intragastric administration for 6 consecutive weeks. Urinary erythrocytes, urinary proteins, and serum creatinine were detected and HE staining was performed to assess renal injury in rats. Lung hemorrhage was observed by gross dissection and microscopic Prussian blue staining. The level of serum MPO-ANCA was detected. Serum IL-6, TNF-α, superoxide dismutase (SOD), and glutathione peroxidase (GSH-px) in rats were measured to explore the effects of ATX on oxidative stress and inflammation in EAV rats. The deposition of MPO in kidney and lung of rats was detected by immunohistochemistry.

Results: ATX significantly inhibited neutrophil secretion of inflammatory factors IL-6 and TNF-α. ATX reduced the elevated levels of ROS in neutrophils stimulated by serum from AAV patients and alleviated the release of NETs. ATX administration was observed to reduce the degree of hematuria, proteinuria, and glomerular crescent formation in EAV rats. The degree of pulmonary hemorrhage was significantly reduced. Besides, the serum levels of IL-6 and TNF-α were attenuated, and antioxidant SOD and GSH-px increased in serum. Pathological results showed that MPO deposition was decreased in lung and kidney tissues after ATX treatment.

Conclusion: ATX could ameliorate the organ damages in EAV rats. It could serve as a hopeful therapy for AAV by its anti-inflammatory and anti-oxidative feature as a unique nature carotenoid.

Keywords: Anti-neutrophil cytoplasmic antibody-associated vasculitis; Astaxanthin; Inflammation; Neutrophil extracellular traps; Oxidative stress.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / immunology
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / pathology
  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Cells, Cultured
  • Disease Models, Animal
  • Extracellular Traps / drug effects
  • Extracellular Traps / metabolism
  • Female
  • Humans
  • Interleukin-6* / blood
  • Interleukin-6* / metabolism
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / pathology
  • Lung / drug effects
  • Lung / immunology
  • Lung / pathology
  • Male
  • Middle Aged
  • Neutrophils* / drug effects
  • Neutrophils* / immunology
  • Oxidative Stress / drug effects
  • Peroxidase* / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha* / metabolism
  • Xanthophylls* / pharmacology
  • Xanthophylls* / therapeutic use

Substances

  • astaxanthine
  • Xanthophylls
  • Peroxidase
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Reactive Oxygen Species
  • Anti-Inflammatory Agents
  • Antibodies, Antineutrophil Cytoplasmic